Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures
<p>Abstract</p> <p>Background</p> <p>Doxorubicin is considered one of the most potent established chemotherapeutics in the treatment of liposarcoma; however, the response rates usually below 30%, are still disappointing. This study was performed to identify gene expression changes in liposarcoma aft...
Gorde:
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2008-10-01
|
| Saila: | BMC Cancer |
| Sarrera elektronikoa: | http://www.biomedcentral.com/1471-2407/8/313 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|